Neoadjuvant anti-programmed death-1 immunotherapy by pembrolizumab in resectable non-small cell lung cancer: first clinical experience - Eichhorn, Florian; Klotz, Laura Valentina; Kriegsmann, Mark; Bischoff, Helge; Schneider, Marc; Muley, Thomas; Kriegsmann, Katharina; Haberkorn, Uwe; Heußel, Claus Peter; Savai, Rajkumar; Zörnig, Inka; Jäger, Dirk; et al. (Lung cancer, 2021)
Gesehen am 26.08.2021